Visual Impairment News and Research RSS Feed - Visual Impairment News and Research

The definition of vision impairment by the Centers for Disease Control and Prevention (CDC) says a visually impaired person’s eyesight cannot be corrected to a “normal level”.
Sense announces official launch of new deafblind awareness e-learning course for audiologists

Sense announces official launch of new deafblind awareness e-learning course for audiologists

Sense, the national deafblind charity, has today announced the official launch of its new deafblind awareness e-learning course, specifically designed for audiologists. [More]
Newly developed smartphone application may potentially benefit low-vision users

Newly developed smartphone application may potentially benefit low-vision users

Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear/Harvard Medical School have developed a smartphone application that projects a magnified smartphone screen to Google Glass, which users can navigate using head movements to view a corresponding portion of the magnified screen. They have shown that the technology can potentially benefit low-vision users, many of whom find the smartphone's built-in zoom feature to be difficult to use due to the loss of context. Their results are published online in the journal IEEE Transactions on Neural Systems and Rehabilitation Engineering. [More]
Researchers provide new mechanism for age-related macular degeneration

Researchers provide new mechanism for age-related macular degeneration

Age-related macular degeneration (AMD) is the leading cause of visual impairment in people over 50 in developed countries. Although this condition affects up to 20% of people between the ages of 65 and 75, what drives abnormal blood vessels to invade the retina is unknown. [More]
New, regenerative medicine approach developed to remove congenital cataracts in infants

New, regenerative medicine approach developed to remove congenital cataracts in infants

Researchers at University of California, San Diego School of Medicine and Shiley Eye Institute, with colleagues in China, have developed a new, regenerative medicine approach to remove congenital cataracts in infants, permitting remaining stem cells to regrow functional lenses. [More]
Uncorrected refractive error responsible for vision impairment in 101 million people worldwide

Uncorrected refractive error responsible for vision impairment in 101 million people worldwide

Uncorrected refractive error (URE)--nearsightedness, farsightedness, and other focusing problems correctable by prescription lenses--is responsible for moderate to severe vision impairment in 101 million people and blindness in seven million people worldwide, reports a study in the March issue of Optometry and Vision Science, official journal of the American Academy of Optometry. [More]
Homeless adults have more geriatric conditions than those living in homes

Homeless adults have more geriatric conditions than those living in homes

Homeless people in their fifties have more geriatric conditions than those living in homes who are decades older, according to researchers at UC San Francisco who are following 350 people who are homeless and aged 50 and over, in Oakland. [More]

Apps that test visual function at home can identify vision problems long before traditional tests

Apps that test visual function at home can discover deterioration of the eye's macula lutea long before traditional vision tests. A doctoral thesis at Sahlgrenska Academy explored this issue. [More]
LouLou Foundation, Penn Med set up Program of Excellence to develop treatments for children with CDKL5

LouLou Foundation, Penn Med set up Program of Excellence to develop treatments for children with CDKL5

The London-based LouLou Foundation and the Orphan Disease Center of the Perelman School of Medicine at the University of Pennsylvania have established a Program of Excellence to develop effective treatments for children with CDKL5, a rare X-chromosome-linked genetic disorder that causes severe neuro-developmental impairment and early-onset, difficult-to-control seizures. [More]
First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that the first patient has been enrolled in its Phase II CIRCLE study evaluating the efficacy and safety of multiple doses of ocriplasmin in inducing total posterior vitreous detachment (PVD) in patients with non-proliferative diabetic retinopathy (NPDR). [More]
New studies provide insights into impact of vision loss among survivors of childhood cancers

New studies provide insights into impact of vision loss among survivors of childhood cancers

Little is known about the long-term health of survivors of childhood cancers that affect vision, but two new studies provide valuable insights that could impact patient care and follow-up. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society. [More]
Study: Programmable electronic glasses help improve vision in children diagnosed with lazy eye

Study: Programmable electronic glasses help improve vision in children diagnosed with lazy eye

A new study on lazy eye found that programmable electronic glasses help improve vision in children just as well as the more traditional treatment using eye patches. This "digital patch" is the first new effective treatment for lazy eye in half a century. Results from the first U.S. trial of this device will be presented at AAO 2015, the 119th Annual Meeting of the American Academy of Ophthalmology. [More]
AAO announces launch of new online resource to improve eye care for children

AAO announces launch of new online resource to improve eye care for children

The American Academy of Ophthalmology today announced the launch of a new online resource for eye physicians and surgeons dedicated solely to children's ocular diseases and disorders. The Knights Templar Eye Foundation Pediatric Ophthalmology Education Center is an important tool that enables ophthalmologists to better serve the 19 million children worldwide who suffer visual impairment. The new resource will be unveiled this week at AAO 2015, the 119th annual meeting of the American Academy of Ophthalmology. [More]
University of Leicester hosts sports event to raise awareness of Nystagmus

University of Leicester hosts sports event to raise awareness of Nystagmus

The University of Leicester will be hosting an event to introduce sports for people with reduced vision and to raise awareness of the eye condition Nystagmus on Sunday 1 November. [More]
Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

In the UK there are currently over 3.5 million people who have diabetes, with a growth rate exceeding 280,000 people per year. Diabetic retinopathy is the most common complication of diabetes. [More]
QUT's Professor Joanne Wood wins 'Nobel Prize' of international optometry

QUT's Professor Joanne Wood wins 'Nobel Prize' of international optometry

One of the world's leading experts on visual impairment, ageing and driving, QUT's Professor Joanne Wood, has won the "Nobel Prize" of international optometry for her work. [More]
AMD Alliance hosts webinar to promote awareness and knowledge about macular disease

AMD Alliance hosts webinar to promote awareness and knowledge about macular disease

14 – 20 September marks global AMD Awareness Week 2015. Age related macular degeneration (AMD) is a progressive eye disease which is the leading cause of blindness in over 50s globally. [More]
Gene therapy restores visual function in mouse model of LCA1

Gene therapy restores visual function in mouse model of LCA1

Mice lacking the protein retGC1, which is deficient in humans suffering Leber congenital amaurosis-1 (LCA1), a disorder that causes severe visual impairment beginning in infancy, received gene therapy to replace retGC1 and showed fully restored visual function that persisted for at least 6 months. [More]
Researchers receive Bill & Melinda Gates Foundation grant to eliminate neglected tropical diseases

Researchers receive Bill & Melinda Gates Foundation grant to eliminate neglected tropical diseases

Researchers at Washington University School of Medicine in St. Louis have received a $7 million grant from the Bill & Melinda Gates Foundation aimed at eliminating river blindness and elephantiasis, two neglected tropical diseases that annually sicken millions. [More]
Retinal function, structure changes in proliferative diabetic retinopathy revealed

Retinal function, structure changes in proliferative diabetic retinopathy revealed

Patients with proliferative diabetic retinopathy exhibit marked visual dysfunction and structural changes in both the inner and outer retinal layers, research findings indicate. [More]
Benefit and harm of vision screening in preschool-aged children still unclear

Benefit and harm of vision screening in preschool-aged children still unclear

It remains unclear whether a special ophthalmological examination of all children younger than 6 years (and potential follow-up treatments) would reduce the frequency and severity of visual impairment (amblyopia) in the population. An update search conducted for a benefit assessment of the German Institute for Quality and Efficiency in Health Care from 2008 identified no new screening study. [More]
Advertisement
Advertisement